Home » Topics » Regulatory » Patents

Patents
RSS

Antineoplastic cephalomannine derivatives from Xechem with paclitaxel-like activity

Dec. 21, 1998

EP1 receptor antagonists described by Ono for pain, fever and diuresis

Dec. 21, 1998

Compounds for inhibiting matrix metalloproteinases in development at Hoechst Marion Roussel

Dec. 21, 1998

HMR patents new series of tachykinin receptor antagonists for asthma, cough and bronchitis

Dec. 18, 1998

Selective 5-HT1D receptor agonists from MS&D useful for migraine

Dec. 18, 1998

Lilly patents novel mGluR modulators

Dec. 18, 1998

Novel antiviral nucleoside analogues from Glaxo Wellcome, U. Michigan

Dec. 18, 1998

Macrolactam monosaccharide of microbial origin with antifungal and antibacterial activity

Dec. 18, 1998

Leukotriene biosynthesis inhibitors described by Ortho-McNeil for inflammatory disorders

Dec. 18, 1998

Zeneca's new pain-relieving agents revealed in patent literature

Dec. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...